DUBLIN–(BUSINESS WIRE)–The “Biopreservation Media Providers Market by Preservation Condition/Deep Frozen, and Cryogenic/LN2 Vapor Phase Storage), Type of Serum, Type of Biological Sample, Area of Application, Type of Packaging Format, End Users, and Region: Industry Trends and Global Forecasts, 2021-2035” report has been added to ResearchAndMarkets.com’s offering.
This report offers an elaborate study of the current scenario and future potential of the biopreservation media providers market, over the next fourteen years. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in the domain of biopreservation media.
Over the past few years, there has been an evident growth in the pipeline of cell-based products, fueled by the demand for effective therapeutics. However, such products are often temperature sensitive, requiring freezing / cryogenic conditions for transport and storage. In fact, as per a study conducted by the USFDA, across more than 80% submissions for mesenchymal cell-based therapies, it was reported that such products required cryopreservation. Therefore, there is a need to identify preservation strategies that are capable of potentially protecting the genome and proteome while avoiding stress-related genetic selectivity, which is a condition that most of the current preservation methods fail to meet.
Further, the chosen method should enable speedy restoration to normal physiological function. Specifically, the presence of components, such as animal-derived products, serum and proteins, often acts as a bottleneck for the effective preservation of biological samples. Biopreservation can address a number of product-related concerns by successfully combining engineering concepts with advances in cellular and molecular biology. As a result, there has been a shift in the interest of industry stakeholders towards pre-formulated, commercially available biopreservation media, which have already been checked for their quality, efficacy, safety, post preservation high cell recovery, clinical applicability and cost effectiveness.
At present, over 60 players claim to offer more than 190 biopreservation media, intended for storage and preservation of different types of biological samples. Recent trends indicate that the biopreservation media market is expanding at a rapid rate, as improvements in adjacent disciplines, such as stem-cell research, cell therapy, personalized medicine, cell banking and cancer research, are fueling the need for ameliorated storage techniques for biologics.
For instance, Kite Pharma enhanced the stability of its primary oncological product (axacabtagene ciloleucel) from 18 hours to 2 weeks, by transitioning the product to cryopreserved state, easing production limitations and giving logistical flexibility at a lower overall cost. This further provides an opportunity for stakeholders to bring ingenious, improved and relatively economical biopreservation media in the market.
It is worth highlighting that the biopreservation media providers are collaborating with other players in the reparative medicine industry to ensure safe and reliable outcomes. Considering the ever-lasting need for storage and transport of biological samples, as well as supported by the continuous endeavors of the biopreservation media providers to improvise their portfolio, we anticipate an upsurge in the adoption of hypothermic biopreservation media and cryopreservation media, over the coming years.
Companies Mentioned
- Adaptimmune Therapeutics
- Akron Biotech
- Alchimia
- ALSTEM
- American Type Culture Collection
- Appleton Woods
- Applied Biological Materials
- Athena Environmental Sciences
- Aurolab
- AvantBio
- Bausch & Lomb
- Bellicum Pharmaceuticals
- BioLife Solutions
- Biological Industries
- Bio-Rad Laboratories
- Bio-Techne
- BioVerde
- BPS Bioscience
- Brooks Life Sciences
- Caltag Medsystems
- Capricorn Scientific
- Cell Applications
- Cell Biologics
- CELLnTEC Advanced Cell Systems
- Cellular Biomedicine Group
- Cellular Engineering Technologies
- Cellular Technology
- Celprogen
- Celyad
- Charter Medical
- chemQ bioscience
- CLS Cell Lines Service
- Cook MyoSite
- Creative Bioarray
- And Many More Companies!
Key Questions Answered
- Who are the key players engaged in offering biopreservation media?
- What is the most likely preservation condition supported by the biopreservation media offered?
- What are the key geographical regions where biopreservation media providers are located?
- What partnership models are most commonly adopted by stakeholders engaged in the domain of biopreservation media?
- What are the key factors influencing the price of biopreservation media?
- What are the likely market opportunities for different types of biopreservation media in the emerging market?
- What are the anticipated future trends related to biopreservation media providers’ market?
- How is the current and future market opportunity likely to be distributed across key market segments?
Key Topics Covered:
1. PREFACE
2. EXECUTIVE SUMMARY
3. INTRODUCTION
4. MARKET LANDSCAPE
5. KEY INSIGHTS
6. COMPANY COMPETITIVENESS
7. COMPANY PROFILES
8. PARTNERSHIPS AND COLLABORATIONS
9. BOWMAN CLOCK PRICING STRATEGY
10. MARKET SIZING AND OPPORTUNITY ANALYSIS
11. CONCLUSION
12. EXECUTIVE INSIGHTS
13. APPENDIX I: TABULATED DATA
14. APPENDIX II: LIST OF COMPANIES AND ORGANIZATION
For more information about this report visit https://www.researchandmarkets.com/r/exa0n6
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900